-
IUPAC Name:{4-[(10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8S,8aR)-2-methyl-7,8-bis({[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]oxy})-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-12-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]-2,6-dimethoxyphenoxy}phosphonic acid
Supplier Lead time Price, $ Pack Targetmol Chemicals IncShips from: United StatesTo:30 days 7985 mgDescription: Tafluposide is a DNA topoisomerase inhibitor with anti-tumor activity.; CAS: 179067-42-6MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: Tafluposide; F-11782; Product Description: Tafluposide (F-11782) is a DNA topoisomerase inhibitor. Tafluposide has antitumor activity .; Target: Topoisomerase; CAS: 179067-42-6MedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: Tafluposide; F-11782; Product Description: Tafluposide (F-11782) is a DNA topoisomerase inhibitor. Tafluposide has antitumor activity; Target: Topoisomerase; CAS: 179067-42-6For a custom pack size or bulk
please drop us a line:Enquire -
![]()
-
IUPAC Name:(4S)-4-[(2S,3R)-2-[(2S)-6-(5-{[(2R,4aR,6R,7R,8S,8aS)-6-{[(10S,11R,15R,16R)-16-(4-{[2-(dimethylamino)acetyl]oxy}-3,5-dimethoxyphenyl)-14-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]oxy}-8-hydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-7-yl]oxy}-5-oxopentanamido)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-6-(5-{[(2R,4aR,6R,7R,8S,8aS)-6-{[(10S,11R,15R,16R)-16-(4-{[2-(dimethylamino)acetyl]oxy}-3,5-dimethoxyphenyl)-14-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]oxy}-8-hydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-7-yl]oxy}-5-oxopentanamido)-2-{2-[(2S)-2-[(2S)-2-(2-{2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-(5-{[(2R,4aR,6R,7R,8S,8aS)-6-{[(10S,11R,15R,16R)-16-(4-{[2-(dimethylamino)acetyl]oxy}-3,5-dimethoxyphenyl)-14-oxo-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-10-yl]oxy}-8-hydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-7-yl]oxy}-5-oxopentanamido)-3-hydroxybutanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}acetamido)-3-hydroxypropanamido]-5-carbamimidamidopentanamido]acetamido}hexanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]hexanamido]-3-hydroxybutanamido]-4-{[(1S)-3-carboxy-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propyl]carbamoyl}butanoic acid
Supplier Lead time Price, $ Pack MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: ANG1009; Product Description: ANG1009 is a BBB-penatrable anticancer agent. ANG1009 is cytotoxic to a variety of tumor cells and can induce cell cycle arrest. ANG1009 can be used in the study of brain cancer .; Target: Peptide-Drug Conjugates (PDCs); CAS: 1220637-65-9For a custom pack size or bulk
please drop us a line:Enquire -
![]()
